Effect of adenosine receptor agonists and antagonists on morphine-induced catalepsy in mice

European Journal of Pharmacology

Volumn 338, Issue 1, 1997, Pages 11-16

  Zarrindast, Mohammad Reza ^a   Iraie, Faramarz ^a   Heidari, Mohammad Reza ^a   Mohagheghi Badi, Masoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenosine receptor agonist; Adenosine receptor antagonist; Catalepsy; Morphine; Mouse; Naloxone

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; MORPHINE; NALOXONE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULATION;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RECEPTORS, PURINERGIC P1; VASODILATOR AGENTS;

EID: 0030662524     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01221-1     Document Type: Article

References (54)

1. Ariyanayagam A.D., Handley S.L. Effect of sensory stimulation on the potency of cataleptogens. Psychopharmacologia (Berlin). 41:1975;165-167.
2. Beecham I.J., Handley S.L. Potentiation of catalepsy induced by narcotic agents during Haffners test for analgesia. Psychopharmacologia. 40:1974;157-164.
3. Bowker H.M., Chapman A.G. Adenosine analogues. The temperature-dependence of the anticonvulsant effect and inhibition of 3H-D-aspartate release. Biochem. Pharmacol. 35:1986;2949-2953.
4. 3H ]NECA in rat striatal membrane Mol. Pharmacol. 29:1986;331-346.
5. Carlsson A., Lindquist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20:1963;140-144.
6. Casas M., Feree S., Cobos A., Grau J.M., Jane F. Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nugrostriatal pathways. Neuropharmacology. 28:1989;407-409.
7. Cornfield L.J., Hu S., Hurt S.D., Sills M.A. [3H]2-Phenylaminoadenosine ([3H] CV 1808] labels a novel adenosine receptor in rat brain. J. Pharmacol. Exp. Ther. 263:1992;552-561.
8. Costall B., Fortune D.H., Naylor R.J. Involvement of mesolimbic and extrapyramidal nuclei in the motor depressant action of narcotic drugs. J. Pharm. Pharmacol. 30:1978;566-572.
9. Daly J.W. Adenosine receptors: Targets for future drugs. J. Med. Chem. 25:1982;197-207.
10. Daly J.W., Bruns R.F., Snyder S.H. Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthines. Life Sci. 28:1981;2083-2097.
11. Daly J.W., Butts-Lamb P., Padgett W. Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines. Cell Mol. Neurobiol. 3:1983;69-80.
12. Daly J.W., Padgeh W.L., Shamin M.T. Analogs of caffeine and theophylline effect of structural on affinity at adenosine receptors. J. Med. Chem. 29:1986;1305-1308.
13. 2 adenosine receptor regulating coronary blood flow. Biochem. Pharmacol. 35:1986;2467-2481.
14. Delander G., Hopkins C.J. Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception. Neuropharmacology. 26:1987;1791-1794.
15. Duk S., Krugers J., Korf J. The effect of theophylline and immobilization stress on haloperidol-induced catalepsy and on metabolism in the striatum and hippocampus, studied with lactography. Neuropharmacology. 30:1991;469-473.
16. Dunstan R., Broekkamp C.L., Lloyd K.G. Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy. Pharmacol. Biochem. Behav. 14:1981;169-174.
17. Ferre S., Herrera-Marschits M., Grabowska-Anden M., Casas M., Ungerstedt U., Anden N.E. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. Eur. J. Pharmacol. 192:1991;31-37.
18. Fredholm B.B., Vernet L. Morphine increase depolarization induced purine release from rat cortical slices. Acta Physiol. Scand. 104:1978;502-504.
19. Fredholm B.B., Herrera-Marschitz M., Jonzon B., Lindstrom K., Ungerstedt U. On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat. Pharmacol. Biochem. Behav. 19:1983;535-541.
20. 1 adenosine receptors with G-proteins. Biochem. J. 275:1991;651-656.
21. Havemann U., Winkler M., Kuschinsky K. Opioid receptors in the caudate nucleus can mediate EMG recorded rigidity in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 313:1980;139-144.
22. Herrera-Marschitz M., Casas M., Ungerstedt U. Caffeine produces contralateral rotation in rats with unilateral dopamine enervation: Comparisons with apomorphine-induced responses. Psychoparmacology. 94:1988;38-45.
23. Ho I.K., Loh H.H., Way E.L. Cyclic adenosine monophosphate antagonism of morphine analgesia. J. Pharmacol. Exp. Ther. 185:1973;336-346.
24. 1 receptor in vivo. Arch. Physiol. Scand. 125:1985;341-342.
25. Jiang Z.G., Chelack B.J., Phillis J.W. Effects of morphine and caffeine on adenosine release from rat cerebral cortex: Is caffeine a morphine antagonist. Can. J. Physiol. Pharmacol. 58:1980;1513-1515.
26. 2A receptor antagonist with anticataleptic activity. Eur. J. Pharmacol. 256:1994;263-268.
27. Londos C., Cooper D.M.F., Wolf J. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA. 77:1980;2551-2554.
28. 1 selective adenosine agonists. J. Med. Chem. 28:1985;1383-1384.
29. Muley M.P., Balsara J.J., Jadhav J.H., Chandorkar A.G. Involvement of histaminergic mechanisms in the cataleptogenic effect of morphine in mice. J. Pharm. Pharmacol. 34:1982;34-37.
30. Munkvad I., Pakkenberg H., Pandrup A. Aminergic systems in the basal ganglia associated with stereotyped hyperactive behaviour and catalepsy. Brain Behav. Evol. 1:1968;89-100.
31. Pert, A., 1977. Central sites involved in opiate actions. In: Fishman, J. (Ed.), The Based of Addiction. Berlin Dahlem Konferenzen, pp. 299-332.
32. Phillis J.W., Jiang Z.G., Chelack B.J., Wu P.H. Morphine enhances adenosine release from the in vivo rat cerebral cortex. Eur. J. Pharmacol. 65:1979;97-100.
33. Phillis J.W., Jiang Z.G., Chelack B.J., Wu P.H. The effect of morphine on purine and acetylcholine release from rat cerebral cortex: Evidence for a purinergic component in morphines action. Pharmacol. Biochem. Behav. 13:1980;421-427.
34. Racagni G., Bruno F., Iuliano E., Paoletti R. Differential sensitivity to morphine-induced analgesia and motor activity in two inbred strains of mice: Behavioral and biochemical correlations. J. Pharmacol. Exp. Ther. 209:1979;111-116.
35. Sawynok J., Sweeney M.I. The role of purines in nociception. Neuroscience. 32:1989;557-569.
36. Sawynok J., Sweeney M.I., White T.D. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol. Sci. 10:1989;186-189.
37. Sawynok J., Espey M.J., Reid A. 8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaqueductal gray. Neuropharmacology. 30:1991;871-877.
38. Schawbe U., Ukena D., Lohse M.J. Xanthines derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 330:1985;212-221.
39. Smellie F.W., Daly J.W., Dunwiddie T.V., Hoffer B.J. The dextro and levorotatory isomers of phenylisoproryl-adenosine: Stereospecific effects on cyclic AMP formation and evoked synaptic responses in brain slices. Life Sci. 25:1979;1739-1748.
40. Smellie F.W., Davis C.W., Daly J.W., Wells J.N. Alkylxanthines inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and brain phosphodiesterase activity. Life Sci. 24:1979;2475-2482.
41. Stone T.W. The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice. Br. J. Pharmacol. 74:1981;171-176.
42. Sweeney M.I., White T.D., Sawynok J. Adenosine release from the spinal cord may mediate antinociception by intracerebroventricular morphine. Soc. Neurosci. Abstr. 15:1989;371.
43. Ungerstedt, U., Herrera-Marschitz, M., Casa, M., 1981. Are apomorphine, bromocriptine and methylxanthines agonist at the same dopamine receptor? In: Gessa, G.L., Corsini, G.W. (Eds.), Apomorphine and Other Dopaminergics, vol. I, Basic Pharmacology. Raven Press, New York, 85 pp.
44. Van Calker D., Muller M., Hamprechi B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33:1979;999-1005.
45. Van Rossum J.M. The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs. Arch. Int. Pharmacodyn. 160:1966;492-494.
46. Vanderwende C., Spoerlein M.T. Morphine-induced catalepsy in mice. Modification by drugs acting on neurotransmitter system. Neuropharmacology. 18:1979;633-637.
47. Watanabe H., Ikeda M., Watanabe K.J. Properties of rotational behaviour produced by methylxanthine-induced lesions. Pharm. Dyn. 4:1981;301-307.
48. Winkler M., Havmann U., Kushinsky K. Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats. Naunyn Schmiedeberg's Arch. Pharmacol. 318:1982;143-147.
49. 3H -purines from rat brian cerebral cortical prisms Pharmacol. Biochem. Behav. 17:1982;749-755.
50. Zarrindast M.R., Heidari M.R. Involvement of adenosine receptors in mouse thermoregulation. J. Psychopharmacol. 7:1993;365-370.
51. Zarrindast M.R., Fatehi F., Mohagheghi-Badi M. Effects of adenosine agents on apomorphine-induced yawning in rats. Psychopharmacology. 122:1995;292-296.
52. Zarrindast M.R., Modabber M., Sabetkasai M. Influences of different adenosine receptor subtypes on catalepsy in mice. Psychopharmacology. 107:1993;163-167.
53. Zarrindast M.R., Nikfar Sh. Different influences of adenosine receptor agonists and antagonists on morphine antinociception in mice. Gen. Pharmacol. 25:1993;139-142.
54. Zhou Q.Y., Li C., Olah M.E., Johnson R.A., Stiles G.L., Giveli O. Molecular cloning and characterization of an adenosine receptor: The A3 receptor. Proc. Natl. Acad. USA. 89:1992;7432-7436.